Is a patient with a patent and incompetent Great Saphenous Vein (GSV) having a diameter greater than 3 millimeters and reflux time of 2.5 seconds, and a patent and competent Short Saphenous Vein (SSV), indicated for Endovenous Ablation Therapy (EVAT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, the Great Saphenous Vein (GSV) described is indicated for Endovenous Ablation Therapy (EVAT). The GSV shows clear signs of venous insufficiency with a diameter greater than 3 mm and reflux time of 2.5 seconds, which exceeds the pathological threshold of 0.5 seconds, as noted in studies such as 1. These findings indicate significant valve dysfunction allowing backward blood flow. EVAT is an appropriate minimally invasive treatment option that uses heat (typically laser or radiofrequency) to close the incompetent vein, redirecting blood flow through healthier veins. The Short Saphenous Vein (SSV) being patent and competent means it's functioning normally and does not require treatment. Treatment should focus only on the incompetent GSV.

Key Points for Consideration

  • The GSV's diameter and reflux time indicate significant venous insufficiency, making EVAT a suitable treatment option, as supported by guidelines and studies like 1 and 1.
  • EVAT offers advantages over traditional vein stripping, including less pain, faster recovery, and fewer complications, as discussed in 1 and 1.
  • Post-procedure care should include compression therapy for 1-2 weeks and regular walking to promote circulation, as generally recommended for such procedures.
  • The decision to proceed with EVAT should be based on symptoms, patient preferences, and considerations of cost, potential complications, and availability of resources, as outlined in 1 and 1.

Treatment Expectations

  • Patients can typically return to normal activities within 1-2 days after the procedure.
  • EVAT effectively addresses the underlying venous insufficiency, improving quality of life, as noted in studies comparing different treatment modalities for varicose veins, such as 1 and 1.

From the Research

Indications for Endovenous Ablation Therapy (EVAT)

The patient's condition involves a great saphenous vein that is patent and incompetent, with a diameter greater than 3 mm and a reflux time of 2.5 seconds. The short saphenous vein is patent and competent.

  • The great saphenous vein's incompetence and significant diameter suggest a potential candidate for EVAT, as indicated by studies such as 2 and 3, which demonstrate the safety and efficacy of endovenous ablation for treating great saphenous vein reflux.
  • The reflux time of 2.5 seconds is within the range that may be considered for intervention, as reflux times greater than 0.5-1 second can be indicative of significant venous insufficiency 4.
  • The fact that the short saphenous vein is patent and competent does not necessarily preclude the use of EVAT for the great saphenous vein, as the treatment of one vein does not directly impact the other 5.

Considerations for EVAT

  • The patient's specific anatomy and reflux pattern should be carefully evaluated to determine the best course of treatment, as different patterns of reflux may require different approaches 6.
  • The use of EVAT for treating great saphenous vein reflux has been shown to be effective in improving symptoms and reducing the risk of recurrence, as demonstrated by studies such as 2 and 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Reflux in the below-knee great saphenous vein can be safely treated with endovenous ablation.

Journal of vascular surgery. Venous and lymphatic disorders, 2014

Research

Editor's Choice - Five Year Results of Great Saphenous Vein Treatment: A Meta-analysis.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2017

Research

Great saphenous vein diameter at the saphenofemoral junction and proximal thigh as parameters of venous disease class.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2013

Research

Endovenous laser ablation (EVLA) of great saphenous vein to abolish "paradoxical reflux" in the Giacomini vein: a short report.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.